| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230262 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
Oral S-1 and concurrent radiotherapy exerted a promising antitumor activity with acceptable toxicity in patients with locally advanced pancreatic cancer. This combination therapy seems to be an attractive alternative to conventional chemoradiotherapy using 5-fluorouracil infusion.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kentaro M.D., Taketo M.D., Takeshi M.D., Kazuyoshi M.D., Taro M.D., Tadamichi M.D., Katsunobu M.D., Toshiyuki M.D., Hitoshi M.D., Mitsuhiro M.D., Kazuo M.D., Hiroyuki M.D., Takashi M.D., Hisao M.D., Osamu M.D.,